The customer reported false negative architect total b-hcg results on a (b)(6) year-old patient.On (b)(6) 2020, the patient sample generated a total b-hcg result of 0.04 miu/ml (<5.00 miu/ml = negative).On (b)(6) 2020, a color ultrasound found that the patient was three months pregnant.The laboratory department retested the sample from the (b)(6) and found that the b-hcg result was >150000 miu/ml (>25 miu/ml = positive).After calibration, the patient sample was retested again, and the results were b-hcg >150000 miu/ml.No impact to patient management was reported.
|
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labelling review, device history record review, field data review.Return testing was not completed as returns were not available.The ticket search determined normal complaint activity for the issue for the product.A review of tracking and trending did not identify any trends for the complaint issue.Device history record review did not identify any issues associated with the complaint lot.The overall performance of architect total b-hcg reagents was reviewed using worldwide field data and suggested that the performance of the lot is acceptable.Additionally, labeling review concluded that the issue is adequately addressed.Based on the investigation, no systemic issue or deficiency of the architect total b-hcg reagent lot 10179ui01 was identified.
|